Related Experiment Videos
Abstract:
17 patients with non-Hodgkin lymphomas were treated by total body irradiation (TBI). 94% went into remission. Response in lymphosarcomas was found to be extremely good with long periods of unmaintained remission. Reticulumcell sarcomas responded poorly.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Stretchable liquid-crystal blue-phase gels.
Nature materials·2014
Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·1984
Half body irradiation (HBI) in metastatic carcinomas.
Clinical radiology·1981
Results of neutron therapy of soft-tissue sarcomas.
Strahlentherapie·1985
Results of curative pion therapy at SIN.
Strahlentherapie·1985
The RENT-project: radiobiological results and planned clinical application.
Strahlentherapie·1985
Neutron and neutron boost irradiation of soft tissue sarcomas.
Strahlentherapie·1985
CAR-Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune-Mediated Inflammation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 - GRACIE trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Aplastic anemia developed after treatment with durvalumab].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Development of memory-like CAR-NK cells with durable antitumor activity].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Curcumin Suppresses Growth of Recurrent Colorectal Adenoma After Endoscopic Resection: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
The American journal of gastroenterology·2026